Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51 ; volume:21 ; number:1 ; day:22 ; month:10 ; year:2019 ; pages:1-18 ; date:12.2019
Breast cancer research ; 21, Heft 1 (22.10.2019), 1-18, 12.2019
- Urheber
-
Lee, Jung Ok
Kang, Min Ju
Byun, Won Seok
Kim, Shin Ae
Seo, Il Hyeok
Han, Jeong Ah
Moon, Ji Wook
Kim, Ji Hae
Kim, Su Jin
Lee, Eun Jung
Park, Serk In
Park, Sun Hwa
Kim, Hyeon Soo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-019-1204-2
- URN
-
urn:nbn:de:101:1-2020021603044333758560
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Jung Ok
- Kang, Min Ju
- Byun, Won Seok
- Kim, Shin Ae
- Seo, Il Hyeok
- Han, Jeong Ah
- Moon, Ji Wook
- Kim, Ji Hae
- Kim, Su Jin
- Lee, Eun Jung
- Park, Serk In
- Park, Sun Hwa
- Kim, Hyeon Soo
- SpringerLink (Online service)
Ähnliche Objekte (12)
A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Analysis of CXCL11 expression in high-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC)
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
Poetry overcomes boundaries
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)
A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Analysis of CXCL11 expression in high-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC)
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
Poetry overcomes boundaries
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)
A novel small molecule RAD51 inactivator overcomes imatinib‐resistance in chronic myeloid leukaemia
CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
Analysis of CXCL11 expression in high-grade serous ovarian cancer (HGSOC) and triple-negative breast cancer (TNBC)
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
Poetry overcomes boundaries
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway